EGFR and head and neck squamous cell carcinoma: Additionally, LTB also interacted with methylated epithelial growth factor receptor (EGFR) in head and neck squamous cell carcinoma (HNSCC) to induce cetuximab resistance, leading to unfavourable outcomes.